{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":37,"n_cols":5,"rows_kept":37,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[12,2,12,3],[13,2,13,3],[17,2,17,3],[25,2,25,3],[25,4,25,5],[26,2,26,3],[26,4,26,5],[27,2,27,3],[27,4,27,5],[28,2,28,3],[29,2,29,3],[30,2,30,3],[31,2,31,3],[32,2,32,3],[34,2,34,3],[35,2,35,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910451833303321"]
[null,null,"Titolo",null,"Pediatric psychopharmacology [[electronic resource] ] : principles and practice / / edited by Andrés Martin ... [et al.]"]
[null,null,"Pubbl/distr/stampa",null,"Oxford ; ; New York, : Oxford University Press, c2003"]
[null,null,"ISBN",null,"1-280-83504-4"]
[{"$nulls":4},"9786610835041"]
[{"$nulls":4},"0-19-803245-5"]
[{"$nulls":4},"1-4237-4569-8"]
[null,null,"Descrizione fisica",null,"1 online resource (814 p.)"]
[null,null,"Disciplina",null,"615/.78"]
[null,null,"Soggetti",null,"Pediatric psychopharmacology"]
[{"$nulls":4},"Psychotropic drugs"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Contents; Contributors; SECTION I: BIOLOGICAL BASES OF PEDIATRIC PSYCHOPHARMACOLOGY; I-A: DEVELOPMENTAL PRINCIPLES OF NEUROBIOLOGY AND PSYCHOPHARMACOLOGY; 1. Overview of Brain Development; 2. Synaptic Function and Biochemical Neuroanatomy; 3. Mechanisms of Signal Transduction and Adaptation to Psychotropic Drug Action; 4. Pharmacokinetics I: Developmental Principles; 5. Pharmacokinetics II: Cytochrome P450-Mediated Drug Interactions; I-B: GENETIC PRINCIPLES; 6. Molecular Genetics; 7. Pharmacogenetics; I-C: DEVELOPMENTAL PSYCHOPATHOLOGY"]
[{"$nulls":4},"8. Neurobiology of Attention Regulation and its Disorders9. Neurobiology of Early-Life Stress and its Disorders; 10. Neurobiology of Early-Onset Mood Disorders; 11. Neurobiology of Early-Onset Anxiety Disorders; 12. Neurobiology of Obsessive-Compulsive Disorder; 13. Neurobiology of Tic Disorders, Including Tourette's Syndrome; 14. Neurobiology of Immune-Mediated Neuropsychiatric Disorders; 15. Neurobiology of Childhood Schizophrenia and Related Disorders; 16. Neurobiology of Affiliation: Implications for Autism Spectrum Disorders; 17. Neurobiology of Aggression"]
[{"$nulls":4},"18. Neurobiology of Eating Disorders19. Neurobiology of Substance Abuse and Dependence Disorders; SECTION II: SOMATIC INTERVENTIONS; II-A: PSYCHOTROPIC AGENTS; 20. Stimulants; 21. "]
[{"$nulls":4},"Adrenergic Agonists: Clonidine and Guanfacine; 22. Antidepressants I: Selective Serotonin Reuptake Inhibitors; 23. Antidepressants II: Tricyclic Agents; 24. Antidepressants III: Other Agents; 25. Mood Stabilizers: Lithium and Anticonvulsants; 26. Antipsychotic Agents: Traditional and Atypical; 27. Anxiolytics: Benzodiazepines, Buspirone, and Others; 28. Miscellaneous Compounds: Beta-Blockers and Opiate Antagonists"]
[{"$nulls":4},"II-B: OTHER SOMATIC INTERVENTIONS29. Complementary and Alternative Medicine in Pediatric Psychopharmacology; 30. Electroconvulsive Therapy and Transcranial Magnetic Stimulation; SECTION III: ASSESSMENT AND TREATMENT; III-A: GENERAL PRINCIPLES; 31. Clinical Assessment of Children and Adolescents Treated Pharmacologically; 32. Clinical Instruments and Scales in Pediatric Psychopharmacology; 33. Thinking About Prescribing: The Psychology of Psychopharmacology; 34. Combining Pharmacotherapy and Psychotherapy: An Evidence-Based Approach; III-B: SPECIFIC DISORDERS AND SYNDROMES"]
[{"$nulls":4},"35. Attention-Deficit Hyperactivity Disorder36. Depressive Disorders; 37. Bipolar Disorder; 38. Anxiety Disorders; 39. Obsessive-Compulsive Disorder; 40. Tourette's Syndrome and Other Tic Disorders; 41. Early-Onset Schizophrenia; 42. Autistic and Other Pervasive Developmental Disorders; 43. Post-traumatic Stress Disorder; 44. Eating Disorders; III-C: SPECIAL CLINICAL POPULATIONS; 45. Substance-Abusing Youths; 46. Individuals with Mental Retardation; 47. The Medically Ill Child or Adolescent; 48. Psychopharmacology During Pregnancy: Infant Considerations"]
[{"$nulls":4},"49. Psychopharmacological Treatment of Preschoolers"]
[null,null,null,"Sommario/riassunto","This is a comprehensive text on the use of medication in the treatment of children and adolescents with serious neuropsychiatric disorders. It reconciles recent research findings with good clinical practice."]
[null,"2.","Record Nr.",null,"UNISALENTO991003831479707536"]
[null,null,"Autore",null,"Zolli, Paolo"]
[null,null,"Titolo",null,"Le parole straniere : francesismi, anglicismi, iberismi, germanismi, slavismi, orientalismi, esotismi / di Paolo Zolli"]
[null,null,"Pubbl/distr/stampa",null,"Bologna : Zanichelli, 1992"]
[null,null,"Edizione",null,"[2. ed. /]"]
[null,null,"Descrizione fisica",null,"X, 246 p. ; 25 cm"]
[null,null,"Disciplina",null,"452.4"]
[null,null,"Soggetti",null,"Lingua italiana - Barbarismi"]
[{"$nulls":4},"Lingua italiana - Esotismi"]
[null,null,"Lingua di pubblicazione",null,"Italiano"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]